Transcend Capital Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
4,738
+843
| +22% | +$40.7K | 0.02% | 542 |
|
|
2025
Q1 | $216K | Sell |
3,895
-1,728
| -31% | -$95.8K | 0.02% | 549 |
|
|
2024
Q4 | $271K | Buy |
5,623
+281
| +5% | +$13.6K | 0.02% | 466 |
|
|
2024
Q3 | $308K | Sell |
5,342
-194
| -4% | -$11.2K | 0.02% | 475 |
|
|
2024
Q2 | $269K | Buy |
5,536
+120
| +2% | +$5.82K | 0.02% | 486 |
|
|
2024
Q1 | $263K | Sell |
5,416
-314
| -5% | -$15.3K | 0.02% | 439 |
|
|
2023
Q4 | $285K | Buy |
5,730
+307
| +6% | +$15.3K | 0.03% | 406 |
|
|
2023
Q3 | $291K | Buy |
5,423
+77
| +1% | +$4.13K | 0.03% | 378 |
|
|
2023
Q2 | $288K | Buy |
5,346
+661
| +14% | +$35.6K | 0.03% | 376 |
|
|
2023
Q1 | $255K | Buy |
+4,685
| New | +$255K | 0.03% | 392 |
|
|
2022
Q4 | – | Sell |
-7,389
| Closed | -$281K | – | 524 |
|
|
2022
Q3 | $281K | Sell |
7,389
-496
| -6% | -$18.9K | 0.03% | 373 |
|
|
2022
Q2 | $394K | Buy |
7,885
+720
| +10% | +$36K | 0.04% | 329 |
|
|
2022
Q1 | $368K | Buy |
7,165
+716
| +11% | +$36.8K | 0.03% | 367 |
|
|
2021
Q4 | $323K | Buy |
6,449
+143
| +2% | +$7.16K | 0.03% | 371 |
|
|
2021
Q3 | $315K | Buy |
+6,306
| New | +$315K | 0.03% | 366 |
|
|
2021
Q2 | – | Sell |
-5,482
| Closed | -$271K | – | 412 |
|
|
2021
Q1 | $271K | Buy |
5,482
+191
| +4% | +$9.44K | 0.03% | 331 |
|
|
2020
Q4 | $257K | Buy |
+5,291
| New | +$257K | 0.03% | 319 |
|